591 related articles for article (PubMed ID: 32081200)
41. The NLRP3 Inflammasome: Metabolic Regulation and Contribution to Inflammaging.
Meyers AK; Zhu X
Cells; 2020 Jul; 9(8):. PubMed ID: 32751530
[TBL] [Abstract][Full Text] [Related]
42. Non-coding RNAs: The key regulators in NLRP3 inflammasome-mediated inflammatory diseases.
Feng X; Luo D; Wei G; Zhan F; Hua F; Xu G
Int Immunopharmacol; 2021 Nov; 100():108105. PubMed ID: 34481143
[TBL] [Abstract][Full Text] [Related]
43. Recent Advances of the NLRP3 Inflammasome in Central Nervous System Disorders.
Zhou K; Shi L; Wang Y; Chen S; Zhang J
J Immunol Res; 2016; 2016():9238290. PubMed ID: 27652274
[TBL] [Abstract][Full Text] [Related]
44. The Role of NLRP3 Inflammasome Activation in the Epithelial to Mesenchymal Transition Process During the Fibrosis.
Alyaseer AAA; de Lima MHS; Braga TT
Front Immunol; 2020; 11():883. PubMed ID: 32508821
[TBL] [Abstract][Full Text] [Related]
45. NLRP3 inflammasome-driven pathways in depression: Clinical and preclinical findings.
Kaufmann FN; Costa AP; Ghisleni G; Diaz AP; Rodrigues ALS; Peluffo H; Kaster MP
Brain Behav Immun; 2017 Aug; 64():367-383. PubMed ID: 28263786
[TBL] [Abstract][Full Text] [Related]
46. Role of NLRP3 inflammasome in the pathogenesis of cardiovascular diseases.
Liu D; Zeng X; Li X; Mehta JL; Wang X
Basic Res Cardiol; 2018 Jan; 113(1):5. PubMed ID: 29224086
[TBL] [Abstract][Full Text] [Related]
47. Regulatory Mechanisms of the NLRP3 Inflammasome, a Novel Immune-Inflammatory Marker in Cardiovascular Diseases.
An N; Gao Y; Si Z; Zhang H; Wang L; Tian C; Yuan M; Yang X; Li X; Shang H; Xiong X; Xing Y
Front Immunol; 2019; 10():1592. PubMed ID: 31354731
[TBL] [Abstract][Full Text] [Related]
48. Strategies for Targeting the NLRP3 Inflammasome in the Clinical and Preclinical Space.
Schwaid AG; Spencer KB
J Med Chem; 2021 Jan; 64(1):101-122. PubMed ID: 33351619
[TBL] [Abstract][Full Text] [Related]
49. Induction of NLRP3 Inflammasome Activation by Heme in Human Endothelial Cells.
Erdei J; Tóth A; Balogh E; Nyakundi BB; Bányai E; Ryffel B; Paragh G; Cordero MD; Jeney V
Oxid Med Cell Longev; 2018; 2018():4310816. PubMed ID: 29743981
[TBL] [Abstract][Full Text] [Related]
50. Nuclear Factor E2-Related Factor-2 Negatively Regulates NLRP3 Inflammasome Activity by Inhibiting Reactive Oxygen Species-Induced NLRP3 Priming.
Liu X; Zhang X; Ding Y; Zhou W; Tao L; Lu P; Wang Y; Hu R
Antioxid Redox Signal; 2017 Jan; 26(1):28-43. PubMed ID: 27308893
[TBL] [Abstract][Full Text] [Related]
51. Pharmacological Inhibition of the NLRP3 Inflammasome: Structure, Molecular Activation, and Inhibitor-NLRP3 Interaction.
Ma Q
Pharmacol Rev; 2023 May; 75(3):487-520. PubMed ID: 36669831
[TBL] [Abstract][Full Text] [Related]
52. NLRP3 inflammasome activation, metabolic danger signals, and protein binding partners.
Leu SY; Tsang YL; Ho LC; Yang CC; Shao AN; Chang CY; Lin HK; Tsai PJ; Sung JM; Tsai YS
J Endocrinol; 2023 May; 257(2):. PubMed ID: 36799299
[TBL] [Abstract][Full Text] [Related]
53. Phytochemicals as Novel Therapeutic Strategies for NLRP3 Inflammasome-Related Neurological, Metabolic, and Inflammatory Diseases.
Pellegrini C; Fornai M; Antonioli L; Blandizzi C; Calderone V
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31200447
[TBL] [Abstract][Full Text] [Related]
54. Signal transduction analysis of the NLRP3-inflammasome pathway after cellular damage and its paracrine regulation.
Veltman D; Laeremans T; Passante E; Huber HJ
J Theor Biol; 2017 Feb; 415():125-136. PubMed ID: 28017802
[TBL] [Abstract][Full Text] [Related]
55. [Regulation of the NLRP3 inflammasome].
Groslambert M; Py BF
Med Sci (Paris); 2018 Jan; 34(1):47-53. PubMed ID: 29384096
[TBL] [Abstract][Full Text] [Related]
56. Autophagy, NLRP3 inflammasome and auto-inflammatory/immune diseases.
Zhong Z; Sanchez-Lopez E; Karin M
Clin Exp Rheumatol; 2016; 34(4 Suppl 98):12-6. PubMed ID: 27586797
[TBL] [Abstract][Full Text] [Related]
57. Calcium-sensing receptor activates the NLRP3 inflammasome in LS14 preadipocytes mediated by ERK1/2 signaling.
D'Espessailles A; Mora YA; Fuentes C; Cifuentes M
J Cell Physiol; 2018 Aug; 233(8):6232-6240. PubMed ID: 29345311
[TBL] [Abstract][Full Text] [Related]
58. NLRP3 inflammasome in ischemic stroke: As possible therapeutic target.
Alishahi M; Farzaneh M; Ghaedrahmati F; Nejabatdoust A; Sarkaki A; Khoshnam SE
Int J Stroke; 2019 Aug; 14(6):574-591. PubMed ID: 30940045
[TBL] [Abstract][Full Text] [Related]
59. Involvement of c-Abl Kinase in Microglial Activation of NLRP3 Inflammasome and Impairment in Autolysosomal System.
Lawana V; Singh N; Sarkar S; Charli A; Jin H; Anantharam V; Kanthasamy AG; Kanthasamy A
J Neuroimmune Pharmacol; 2017 Dec; 12(4):624-660. PubMed ID: 28466394
[TBL] [Abstract][Full Text] [Related]
60. Regulation and Function of the Nucleotide Binding Domain Leucine-Rich Repeat-Containing Receptor, Pyrin Domain-Containing-3 Inflammasome in Lung Disease.
Lee S; Suh GY; Ryter SW; Choi AM
Am J Respir Cell Mol Biol; 2016 Feb; 54(2):151-60. PubMed ID: 26418144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
